Rachel Westergren

Recommended Articles

• Staying Active with Parkinson's Disease

  Parkinson’s disease is a neuromuscular degenerative disorder that robs those afflicted of their motor functions over time. The disease is generally slow moving, but studies have shown that persons with Parkinson's that were active before their diagnosis and continue to be so afterwards, seem to...

• How Does the Body Turn Carbohydrates into Glucose?

  What are Carbohydrates?The body converts the food we eat into energy. Even though we obtain calories and energy from different food sources, such as carbohydrates, fats, and proteins, our main source of energy is still from carbohydrates. The body converts these carbs into glucose, which is the main...

• Pleurisy: What to Expect on Your Visit to a Pulmonologist

  As with any disease, your doctor will first speak to you and asks for a detailed history. He or she will do a physical examination to come up with a differential diagnosis. Later, the diagnosis will be confirmed by doing some tests.History TakingExpect your pulmonologist to ask you questions...

• The Relationship Between Sudden Cardiac Death and Sleep Apnea

  Sleep apnea is a common sleep disorder in the United States, although many people don't realize that it can be very dangerous. It is often called a minor sleep disturbance, without realizing the fact that it is associated with many life-threatening conditions.Sleep apnea can increase blood pressure,...

• What Are the Heart Health Benefits of Arginine?

  Arginine is an essential amino acid that has been in the spot light among hundreds of other nutrients because of its benefits to the heart. For many people diagnosed with heart disease, the heart-healthy benefits of this nutrient have come to the forefront. Arginine is a semi-essential amino acid...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...